A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
GlaxoSmithKline
Peking University People's Hospital
Barbara Ann Karmanos Cancer Institute
Icahn School of Medicine at Mount Sinai
University of Iowa
University of Athens
Peking Union Medical College Hospital
Guangdong Provincial People's Hospital
SWOG Cancer Research Network
PETHEMA Foundation
Mayo Clinic
National Cancer Institute (NCI)
Mayo Clinic
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Northwestern University
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center